BioNexus Gene Lab (BGLC) Capital Expenditures (2018 - 2026)
BioNexus Gene Lab recorded quarterly Capital Expenditures of $325.0 in Q1 2026, down 66.73% quarter-over-quarter from $977.0 in Q4 2025, and down 96.41% year-over-year from $9052.0 in Q1 2025.
BioNexus Gene Lab's Capital Expenditures history runs 9 years deep, the most recent figure standing at $325.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 96.41% year-over-year to $325.0; the TTM figure through Mar 2026 stood at $28244.0 (down 86.81% YoY), while the FY2025 annual figure was $36971.0, down 83.71% from the prior year.
- Capital Expenditures came in at $325.0 for Q1 2026 at BioNexus Gene Lab, down from $977.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $199189.0 in Q3 2024 to a low of -$32191.0 in Q2 2022.
- A 5-year average of $27578.9 and a median of $5483.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 4933.48% in 2022 and jumped 21414.71% in 2024, its largest moves.
- BioNexus Gene Lab's Capital Expenditures stood at -$32191.0 in 2022, then soared by 102.91% to $937.0 in 2023, then soared by 329.24% to $4022.0 in 2024, then plunged by 75.71% to $977.0 in 2025, then tumbled by 66.73% to $325.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $325.0, $977.0, and $5483.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 1.34 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 138.30 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 332.10 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | - |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 52.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 269.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 98.68 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 102.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 325.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 325.00 |
| Mar 31, 2026 | 325.00 |
| Dec 31, 2025 | 977.00 |
| Dec 31, 2025 | 977.00 |
| Sep 30, 2025 | 5,483.00 |
| Sep 30, 2025 | 5,483.00 |
| Jun 30, 2025 | 21,459.00 |
| Jun 30, 2025 | 21,459.00 |
| Mar 31, 2025 | 9,052.00 |
| Mar 31, 2025 | 9,052.00 |
| Dec 31, 2024 | 4,022.00 |
| Dec 31, 2024 | 4,022.00 |
| Sep 30, 2024 | 199,189.00 |
| Sep 30, 2024 | 199,189.00 |
| Jun 30, 2024 | 1,833.00 |
| Jun 30, 2024 | 1,833.00 |
| Mar 31, 2024 | 21,945.00 |
| Mar 31, 2024 | 21,945.00 |
| Dec 31, 2023 | 937.00 |
| Dec 31, 2023 | 937.00 |
| Sep 30, 2023 | 106,874.00 |
| Sep 30, 2023 | 106,874.00 |
| Jun 30, 2023 | 41,485.00 |
| Jun 30, 2023 | 41,485.00 |
| Mar 31, 2023 | 102.00 |
| Mar 31, 2023 | 102.00 |
| Dec 31, 2022 | 17,027.00 |
| Dec 31, 2022 | 17,027.00 |
| Sep 30, 2022 | 37,144.00 |
| Sep 30, 2022 | 37,144.00 |
| Jun 30, 2022 | -32,191.00 |
| Jun 30, 2022 | -32,191.00 |
| Mar 31, 2022 | 32,191.00 |
| Mar 31, 2022 | 32,191.00 |
| Dec 31, 2021 | 1,279.00 |
| Dec 31, 2021 | 1,279.00 |
| Sep 30, 2021 | 410.00 |
| Sep 30, 2021 | 410.00 |
| Jun 30, 2021 | 666.00 |
| Jun 30, 2021 | 666.00 |
| Mar 31, 2021 | 807.00 |
| Mar 31, 2021 | 807.00 |
| Dec 31, 2020 | 421,316.00 |
| Dec 31, 2020 | 421,316.00 |
| Jun 30, 2020 | -2.00 |
| Jun 30, 2020 | -2.00 |
| Mar 31, 2020 | 307.00 |
| Mar 31, 2020 | 307.00 |
| Dec 31, 2019 | 7,145.00 |
| Dec 31, 2019 | 7,145.00 |
| Sep 30, 2019 | -3,532.00 |
| Sep 30, 2019 | -3,532.00 |
| Jun 30, 2019 | 23,835.00 |
| Jun 30, 2019 | 23,835.00 |
| Mar 31, 2019 | -14,631.00 |
| Mar 31, 2019 | -14,631.00 |
| Dec 31, 2018 | -17,292.00 |
| Dec 31, 2018 | -17,292.00 |
| Mar 31, 2018 | -17,190.00 |
| Mar 31, 2018 | -17,190.00 |